Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method
International Journal of Molecular Sciences · 14.01.2025 · 26 (2) · 670
DOI: 10.3390/ijms26020670 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.01.2025. Verfasst von Lanlan Jing und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of …. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Coronavirus 3C Proteases, COVID-19 Drug Treatment. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program, Shandong Laboratory Program.
Abstract (Originalsprache)
With the aim of developing novel anti-SARS-CoV-2 drugs to address the ongoing evolution and emergence of drug-resistant strains, the reported SARS-CoV-2 Mpro inhibitor WU-04 was selected as a lead to find novel, highly potent, and broad-spectrum inhibitors. Using a fragment-based multilevel virtual screening strategy, 15 hit compounds were identified and subsequently synthesized. Among them, A5 (IC50 = 1.05 μM), A6 (IC50 = 1.08 μM), and A9 (IC50 = 0.154 μM) demonstrated potent SARS-CoV-2 Mpro inhibition comparable to or slightly weaker than WU-04. Antiviral activity evaluations revealed that compound A9 exhibited the strongest antiviral activity with an EC50 value of 0.18 μM, quite comparable to the marketed drug Nirmatrelvir (EC50 = 0.123 μM) and inferior to WU-04 (EC50 = 0.042 μM). Molecular dynamics simulations elucidated the key interactions between compounds A5, A6, A9, and the binding pocket of SARS-CoV-2 Mpro, providing valuable insights into their mechanisms of action. These findings identify compound A9 as a promising lead for anti-SARS-CoV-2 drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, Jinan 250012, Chi…
- Antiviral Drug & Vaccine Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
- Molecular, Structural and Translational Virology Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
- China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Shandong University, 44 West Culture Road, Jinan 250012, China.
ORCID-Profile: Manon Laporte, Dirk Jochmans, Steven De Jonghe, Johan Neyts, Peng Zhan, Dongwei Kang, Xinyong Liu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program
- Shandong Laboratory Program
- Taishan Scholar Program of Shandong Province
- Hercules Foundation (Research Foundation Flanders) and Rega Foundation, KU Leuven
- Qilu Young Scholars Program of Shandong University
- Hercules Foundation (Research Foundation Flanders)
Zitieren
APA
Jing, L., Zhao, F., Zheng, L., Meng, B., Gao, S., Laporte, M., Jochmans, D., De Jonghe, S., Neyts, J., Zhan, P., Kang, D., & Liu, X. (2025). Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method. International Journal of Molecular Sciences, 26(2), 670. https://doi.org/10.3390/ijms26020670
Vancouver
Jing L, Zhao F, Zheng L, Meng B, Gao S, Laporte M, et al. Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method. International Journal of Molecular Sciences. 2025;26(2):670. doi:10.3390/ijms26020670
BibTeX
@article{Jing2025,
author = {Jing, Lanlan and Zhao, Fabao and Zheng, Lin and Meng, Bairu and Gao, Shenghua and Laporte, Manon and Jochmans, Dirk and De Jonghe, Steven and Neyts, Johan and Zhan, Peng and Kang, Dongwei and Liu, Xinyong},
title = {Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {2},
pages = {670},
doi = {10.3390/ijms26020670}
}
EUVIMED